Hill-Rom Holdings ROE 2006-2018 | HRC

Current and historical return on equity (ROE) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Hill-Rom Holdings ROE for the three months ending September 30, 2018 was 21.10%.
Hill-Rom Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.25B $1.62B 16.53%
2018-06-30 $0.23B $1.51B 15.80%
2018-03-31 $0.19B $1.51B 13.64%
2017-12-31 $0.20B $1.46B 14.66%
2017-09-30 $0.13B $1.37B 10.42%
2017-06-30 $0.12B $1.29B 9.33%
2017-03-31 $0.16B $1.25B 12.70%
2016-12-31 $0.14B $1.20B 11.90%
2016-09-30 $0.12B $1.24B 10.42%
2016-06-30 $0.06B $1.20B 5.30%
2016-03-31 $0.04B $1.18B 3.39%
2015-12-31 $0.04B $1.15B 4.22%
2015-09-30 $0.05B $1.16B 5.55%
2015-06-30 $0.08B $0.77B 10.79%
2015-03-31 $0.09B $0.72B 11.48%
2014-12-31 $0.06B $0.74B 7.54%
2014-09-30 $0.06B $0.81B 7.44%
2014-06-30 $0.07B $0.83B 8.52%
2014-03-31 $0.07B $0.80B 8.23%
2013-12-31 $0.09B $0.84B 11.23%
2013-09-30 $0.10B $0.86B 12.63%
2013-06-30 $0.11B $0.81B 13.30%
2013-03-31 $0.11B $0.81B 13.27%
2012-12-31 $0.11B $0.82B 13.69%
2012-09-30 $0.12B $0.81B 15.04%
2012-06-30 $0.15B $0.81B 18.58%
2012-03-31 $0.12B $0.80B 16.19%
2011-12-31 $0.13B $0.77B 17.45%
2011-09-30 $0.13B $0.74B 17.96%
2011-06-30 $0.12B $0.75B 16.40%
2011-03-31 $0.15B $0.76B 20.87%
2010-12-31 $0.14B $0.73B 20.41%
2010-09-30 $0.13B $0.71B 18.95%
2010-06-30 $0.10B $0.68B 15.78%
2010-03-31 $0.09B $0.65B 14.48%
2009-12-31 $-0.40B $0.63B -66.20%
2009-09-30 $-0.41B $0.61B -56.92%
2009-06-30 $-0.41B $0.60B -49.05%
2009-03-31 $-0.41B $0.58B -42.91%
2008-12-31 $0.08B $1.06B 7.86%
2008-09-30 $0.12B $1.08B 10.17%
2008-06-30 $0.14B $1.08B 11.79%
2008-03-31 $0.16B $1.05B 12.67%
2007-12-31 $0.18B $1.31B 14.55%
2007-09-30 $0.19B $1.28B 15.53%
2007-06-30 $0.21B $1.26B 17.59%
2007-03-31 $0.23B $1.22B 19.60%
2006-12-31 $0.23B $1.17B 20.40%
2006-09-30 $0.22B $1.13B 20.84%
2006-06-30 $-0.08B $1.07B -7.45%
2006-03-31 $-0.09B $1.04B -8.63%
2005-12-31 $-0.09B $1.00B -8.52%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.270B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00